We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIXY icon
6326
ProShares VIX Short-Term Futures ETF
VIXY
$182M
$31K ﹤0.01%
+13
New +$33.2K
WVVI icon
6327
Willamette Valley Vineyards
WVVI
$12M
$31K ﹤0.01%
3,628
+1,807
+99% +$14.8K
XPRO icon
6328
Expro Ltd
XPRO
$1.91B
$31K ﹤0.01%
658
-1,131
-63% -$48K
ESHY
6329
DELISTED
Xtrackers J.P. Morgan ESG USD High Yield Corporate Bond ETF
ESHY
$31K ﹤0.01%
1,371
-446
-25% -$10.2K
ACER
6330
DELISTED
Acer Therapeutics Inc
ACER
$31K ﹤0.01%
+1,429
New +$27.1K
UBP
6331
DELISTED
Urstadt Biddle Properties Inc.
UBP
$31K ﹤0.01%
1,664
-192
-10% -$3.3K
SAL
6332
DELISTED
Salisbury Bancorp, Inc.
SAL
$31K ﹤0.01%
1,474
+282
+24% +$6.17K
SPNE
6333
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$31K ﹤0.01%
2,498
+1,991
+393% +$23.8K
GBL
6334
DELISTED
GAMCO Investors, Inc.
GBL
$31K ﹤0.01%
1,141
+550
+93% +$14.2K
NRCG
6335
DELISTED
NRC Group Holdings Corp.
NRCG
$31K ﹤0.01%
3,055
+450
+17% +$4.5K
WREI
6336
DELISTED
Invesco Wilshire US REIT ETF
WREI
$31K ﹤0.01%
671
-12
-2% -$522
HILO
6337
DELISTED
Columbia EM Quality Dividend ETF
HILO
$31K ﹤0.01%
2,136
-21
-1% -$320
RUSL
6338
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
$31K ﹤0.01%
729
-1,325
-65% -$57.4K
HJPX
6339
DELISTED
iShares Currency Hedged JPX-Nikkei 400 ETF
HJPX
$31K ﹤0.01%
1,051
+700
+199% +$20.7K
DDG
6340
DELISTED
Proshares Short Oil & Gas
DDG
$31K ﹤0.01%
1,476
-200
-12% -$4.35K
TIBRU
6341
DELISTED
Tiberius Acquisition Corporation Units
TIBRU
$31K ﹤0.01%
3,058
+2,828
+1,230% +$28.6K
GCVRZ
6342
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$31K ﹤0.01%
62,596
-16,082
-20% -$7.49K
ACNB icon
6343
ACNB Corp
ACNB
$661M
$30K ﹤0.01%
+878
New +$27.3K
ADMA icon
6344
ADMA Biologics
ADMA
$2.33B
$30K ﹤0.01%
6,740
+3,667
+119% +$18.3K
ATEX icon
6345
Anterix
ATEX
$1.96B
$30K ﹤0.01%
1,200
+450
+60% +$12.5K
ATRA icon
6346
Atara Biotherapeutics
ATRA
$74.3M
$30K ﹤0.01%
33
-4,086
-99% -$4.39M
BCML icon
6347
BayCom
BCML
$335M
$30K ﹤0.01%
+1,199
New +$28.8K
DHR icon
6348
PUT
Danaher
DHR
$141B
$30K ﹤0.01%
338
-10,829
-97% -$965K
DUSL icon
6349
Direxion Daily Industrials Bull 3X ETF
DUSL
$61.2M
$30K ﹤0.01%
1,005
+337
+50% +$11K
EBMT icon
6350
Eagle Bancorp Montana
EBMT
$191M
$30K ﹤0.01%
1,571
+499
+47% +$9.93K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.